Broocks, Gabriel http://orcid.org/0000-0002-7575-9850
Meyer, Lukas
Kabiri, Reza
Kniep, Helge C.
McDonough, Rosalie
Bechstein, Matthias
van Horn, Noel
Lindner, Thomas
Sedlacik, Jan
Cheng, Bastian
Thomalla, Götz
Schön, Gerhard
Fiehler, Jens
Hanning, Uta
Schönfeld, Michael H.
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 8 January 2021
Revised: 21 March 2021
Accepted: 1 April 2021
First Online: 8 May 2021
Declarations
:
: The scientific guarantor of this publication is Gabriel Broocks.
: The authors of this manuscript declare relationships with the following companies:Jens Fiehler: Consultant for Acandis, Boehringer Ingelheim, Codman, Microvention, Sequent, Stryker.Speaker for Bayer Healthcare, Bracco, Covidien/ev3, Penumbra, Philips, Siemens. Grants from Bundesministeriums für Wirtschaft und Energie (BMWi), Bundesministerium für Bildung und Forschung, Deutsche Forschungsgemeinschaft (DFG), European Union, Covidien, Stryker (THRILL study), Microvention (ERASER study), Philips.Götz Thomalla: Personal fees as consultant/lecturer 288 from Acandis, Bayer, Boehringer Ingelheim,Bristol-Myers Squibb/Pfizer, Daichi Sankyo, Stryker, and research grants from Bayer, BMWi, Corona-Foundation, DFG, Else Kröner-Fresenius Foundation, European Union (Horizon 2020), German Innovation Fund.All other authors have no conflict of interest.
: Gerhard Schön kindly provided statistical advice for this manuscript.
: Written informed consent was waived by the Institutional Review Board.
: Institutional Review Board approval was obtained.
: • prospective• observational• performed at one institution